neurobopharma.com - שווי עסקי להכנסות NRBO

NeuroBo Pharmaceuticals (NRBO) is implementing AI and robotics to accelerate the development of neuropreparations. The EV/Revenue multiple reflects the asset's current dynamics, where determines the current status of the parameter. However, the risk of failed trials for obesity and liver drugs creates threats, despite colossal demand in the metabolic and neurological disorder niches.
NeuroBo Pharmaceuticals Inc - פילוחים אנליטיים ומדדי מפתח (NRBO)

A comparative asset analysis requires an evaluation of business value excluding debt, which allows for the determination of the actual market price per unit of revenue. This methodology compares the total enterprise value with its revenues, reflecting investment expectations regarding the success of NeuroBo Pharmaceuticals (NRBO) in developing anti-obesity drugs, which clearly captures the EV/Sales multiple level.